SCHEMBL7778103

SCHEMBL7778103

C#CCn1nc(-c2ccc(S(N)(=O)=O)cc2)c(-c2ccccc2)c1C(F)(F)F

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 15/20 0.62
PTGS1 P23219 5/20 0.62
PDPK1 O15530 2/20 0.46
LDHA P00338 1/20 0.43
CA12 O43570 2/20 0.42
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
CA9 Q16790 2/20 0.42
MT-CO2 P00403 1/20 0.42
LMNA P02545 1/20 0.42
CA3 P07451 1/20 0.42
ADRB2 P07550 1/20 0.42
ADRB1 P08588 1/20 0.42
CYP3A4 P08684 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
CHRM1 P11229 1/20 0.42
ADRA2B P18089 1/20 0.42
CA4 P22748 1/20 0.42
CA6 P23280 1/20 0.42
SLC6A2 P23975 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7773122 0.91 PTGS2 (0.74) PTGS2PTGS1CA12CA1CA2
SCHEMBL7779568 0.90 PTGS2 (0.64) PTGS2PTGS1PDPK1CA12CA1
SCHEMBL7780048 0.90 PTGS2 (0.61) PTGS2PTGS1PDPK1LDHACA12
SCHEMBL7777698 0.90 PTGS2 (0.61) PTGS2PTGS1PDPK1LDHACA12
SCHEMBL7780131 0.90 PTGS2 (0.61) PTGS2PTGS1PDPK1CA12CA1
SCHEMBL7773231 0.89 PTGS2 (0.64) PTGS2PTGS1
SCHEMBL7779690 0.89 PTGS2 (0.62) PTGS2PTGS1PDPK1LDHACA12
SCHEMBL7778238 0.88 PTGS2 (0.60) PTGS2PTGS1PDPK1CA12CA1
SCHEMBL7777315 0.88 PTGS2 (0.60) PTGS2PTGS1CA12CA1CA2
SCHEMBL7779821 0.87 PTGS2 (0.54) PTGS2PTGS1PDPK1CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed